Search filters

List of works by Angelica Calleri

A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.

scientific article

Angiogenic cells, macroparticles and RNA transcripts in laparoscopic vs open surgery for colorectal cancer.

scientific article

Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells

scientific article

Circulating endothelial cell number and viability are reduced by exposure to high altitude.

scientific article published in January 2008

Circulating endothelial cells and circulating endothelial progenitors.

scientific article published on January 2012

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

scientific article published on 16 March 2006

Circulating perivascular progenitors: a target of PDGFR inhibition.

scientific article

Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer.

scientific article published on 5 August 2013

If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.

scientific article

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.

scientific article

Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan

scientific article

The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells

scientific article published on 18 September 2014

Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.

scientific article published in January 2009

Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma.

scientific article published on 26 April 2018